INTRODUCTION {#s1}
============

Alcohol-induced osteonecrosis of the femoral head (ONFH) is a degenerative lesion of joints and a partial blood circulation disorder of the femoral head. It has several complex causes that are common to non-traumatic ONFH and results in further osteocyte ischemia, necrosis, bone trabecula fracture, and complete collapse of the femoral head \[[@R1]\]. It causes a destructive femoral head collapse in approximately 80% of patients without treatment \[[@R2], [@R3]\]. Because drinking has become a global health concern, the World Health Organization (WHO) has identified high alcohol consumption as one of the most important pathogenic factors of alcohol-induced ONFH (<http://www.who.int/entity/substanceabuse/publications/globalalcoholreport/msbgsrwpr.pdf>), and the incidence of this disease is rising worldwide. For example, the overall number of osteonecrosis cases in China has almost reached 7 million and 100,000 to 200,000 new patients are diagnosed each year \[[@R4]\], approximately one-third of whom have alcohol-induced ONFH. This multifactorial disease is the result of several complicated interactions among environmental, lifestyle, metabolic and genetic factors \[[@R5]--[@R7]\]. The widely known pathologic mechanisms of alcohol-induced ONFH are dyslipidemia, osteoporosis, intraosseous hypertension, gene-associated mechanisms, and the abnormal differentiation of osteoblasts/osteoclasts from bone marrow mesenchymal stem cells (BMSCs), and most of the mechanisms are related to the pathologic process of dyslipidemia. So, more investigation of the pathologic mechanisms of alcohol-induced ONFH from different perspectives is needed. Genetic research offers insight into the occurrence, treatment and development of alcohol-induced ONFH, and genetic variations are identified as a normal biological phenomenon that influences immunoreaction and protein transcription and even determine individual susceptibilities of some pathological diseases of the joints \[[@R8]--[@R10]\]. Although many people drink, only some of them experience alcohol-induced ONFH, illustrating that individual susceptibilities might cause different incidences of this disease among different populations. Single-nucleotide polymorphisms (SNPs) have been widely researched because of their variations in a single base pair in the DNA sequence. On the basis of previous studies, we found the polymorphisms of several genes, including *ApoA1*, *ApoB*, *SREBF1* and *TLR4* were associated with the risk of alcohol-induced ONFH \[[@R4], [@R11]--[@R13]\].

Matrix metalloproteinases (MMPs) are a family of proteases that could be involved in the degradation of osseous tissue and other extracellular matrices in the human body. Among the more than 20 types of MMP genes, *MMP-3* and *MMP-8* are the most influential. *MMP-3* encodes an enzyme that degrades fibronectin, laminin, collagens III, IV, IX, and X, and cartilage proteoglycans \[[@R14]\]. *MMP-8* is involved in the breakdown of the extracellular matrix in embryonic development, reproduction, and tissue remodeling \[[@R15]\]. Previous studies show that several types of *MMPs* are abnormally expressed in different orthopedic diseases. *MMP-1* and *MMP-3* are overexpressed in the synoviocytes and chondrocytes of osteoarthritis patients. *MMP-2* and *MMP-9* are overexpressed in the serum and synovia of osteoarthritis patients \[[@R16]\]. Collectively, the dynamic equilibrium of MMPs and their natural inhibitors, tissue inhibitors of metalloproteinases (TIMPs), can significantly influence bone metabolism in the human body \[[@R17]\]. However, no studies have explored the relation between *MMP-3* and *MMP-8* in the MMP/TIMP pathway and alcohol-induced ONFH. Our case-control study investigated whether *MMP-3* and *MMP-8* have a potential association with alcohol-induced ONFH among a population of Chinese males at a genetic level.

RESULTS {#s2}
=======

We performed a case-control study that selected 695 individuals, including 299 alcohol-induced ONFH patients (mean age: 43.24 ± 13.07) and 396 healthy control subjects (mean age: 47.62 ± 10.28). All the individuals are males (Table [1](#T1){ref-type="table"}). We researched eight SNPs (rs639752, rs650108, rs520540, rs646910, rs602128, rs679620, rs678815, and rs522616) on gene *MMP-3* and five SNPs (rs3740938, rs2012390, rs1940475, rs11225394, and rs11225395) on gene *MMP-8*. The basic SNP information of all the individuals in our study, including the minor allele frequency (MAF), odds ratios (ORs), 95% confidence intervals (95% CIs), position, band, alleles, and the *P-*values of alleles evaluated by χ^2^ test, are shown in Table [2](#T2){ref-type="table"}. All 13 SNPs are in accord with the Hardy-Weinberg equilibrium (HWE) (*P* \> 0.05). The minor allele G of rs650108 on *MMP-3* was significantly associated with 0.78-fold decreased alcohol-induced ONFH risk (OR = 0.78, 95% CI = 0.63-0.97, *P* = 0.026). All the primers utilized for genotyping in this study are listed in Table [7](#T7){ref-type="table"}, and the statistical power of the SNPs in our study are listed in the Table [8](#T8){ref-type="table"}.

###### Characteristics of the male individuals in controls and alcohol-induced ONFH

        Group     N     Mean    Std. Deviation   Mean±SD       *P*-value
  ----- --------- ----- ------- ---------------- ------------- ----------------
  Age   Case      299   43.24   13.07            43.24±13.07   *P* \< 0.001\*
        Control   396   47.62   10.28            47.62±10.28   

\* *P* values was calculated by Welch\'s t-tests

###### Basic SNP information summary of all the male individuals in our study

  Gene    SNP ID       Position    Band      Alleles A^a^/B   MAF    Role   HWE-*P*             OR(95%CI)   *P*^b^ value      
  ------- ------------ ----------- --------- ---------------- ------ ------ ------------------- ----------- ----------------- ---------
  MMP-3   rs639752     102707339   11q22.3   C/A              0.31   0.36   Intron              0.27        0.82(0.65-1.02)   0.079
  MMP-3   rs650108     102708787   11q22.3   G/A              0.39   0.45   Intron              0.54        0.78(0.63-0.97)   0.026\*
  MMP-3   rs520540     102709425   11q22.3   A/G              0.31   0.36   Coding exon         0.27        0.82(0.65-1.02)   0.079
  MMP-3   rs646910     102709522   11q22.3   A/T              0.08   0.09   Intron (boundary)   0.76        0.83(0.57-1.23)   0.354
  MMP-3   rs602128     102713465   11q22.3   A/G              0.31   0.36   Coding exon         0.51        0.83(0.66-1.04)   0.104
  MMP-3   rs679620     102713620   11q22.3   T/C              0.31   0.36   Coding exon         0.44        0.81(0.65-1.02)   0.074
  MMP-3   rs678815     102713777   11q22.3   G/C              0.31   0.36   Intron              0.33        0.81(0.65-1.02)   0.075
  MMP-3   rs522616     102715048   11q22.3   C/T              0.39   0.34   Promoter            1.00        1.24(1.00-1.55)   0.054
  MMP-8   rs3740938    102587062   11q22.3   A/G              0.23   0.26   Coding exon         0.70        0.83(0.64-1.06)   0.134
  MMP-8   rs2012390    102590777   11q22.3   G/A              0.26   0.3    Intron              0.48        0.79(0.63-1.01)   0.058
  MMP-8   rs1940475    102593248   11q22.3   T/C              0.36   0.39   Coding exon         1.00        0.90(0.73-1.13)   0.371
  MMP-8   rs11225394   102595413   11q22.3   T/C              0.11   0.08   Intron (boundary)   1.00        1.42(0.98-2.05)   0.059
  MMP-8   rs11225395   102596480   11q22.3   A/G              0.35   0.38   Promoter            1.00        0.90(0.72-1.12)   0.336

SNP, single nucleotide polymorphism; MAF, minor allele frequency; HWE, Hardy-Weinberg equilibrium; ORs, odds ratios; CI, confidence interval;

^a^ Minor allele

^b^ *P* were adjusted by gender and age, \* *P* \< 0.05, statistical significance

We developed a hypothesis that compared each minor allele with the corresponding wild-type allele. Every minor allele on an SNP was one risk factor, and we built five different genetic models and used unconditional logistic regression to assess the relation between SNPs and alcohol-induced ONFH risk. The results are shown in Table [3](#T3){ref-type="table"} . We found that rs650108 on *MMP-3* was related to a decreased risk of alcohol-induced ONFH in the dominant model (OR = 0.69, 95% CI = 0.50-0.95, *P* = 0.023) and the log-additive model (OR = 0.78, 95% CI = 0.63-0.97, *P* = 0.025). We also found that rs11225394 on *MMP-8* was related to an increased alcohol-induced ONFH risk in the codominant model (OR = 1.59, 95% CI = 1.08-2.36, *P* = 0.021), the dominant model (OR = 1.54, 95% CI = 1.04-2.27, *P* = 0.030), and the over-dominant model (OR = 1.60, 95% C I = 1.08-2.38, *P* = 0.018).

###### Analysis of the association between SNPs and alcohol-induced ONFH risk in males (based on logistical tests)

  SNP ID               Model          Genotype   Group=control   Group=Alcohol   OR (95% CI)        *P*-value     AIC     BIC
  -------------------- -------------- ---------- --------------- --------------- ------------------ ------------- ------- -------
  rs650108 (MMP-3)     Codominant     A/A        116 (29.4%)     112 (37.6%)     1                  0.064         947.6   961.2
                                      A/G        202 (51.1%)     139 (46.6%)     0.71 (0.51-1.00)                         
                                      G/G        77 (19.5%)      47 (15.8%)      0.63 (0.40-0.99)                         
                       Dominant       A/A        116 (29.4%)     112 (37.6%)     1                  **0.023\***   945.9   955
                                      A/G-G/G    279 (70.6%)     186 (62.4%)     0.69 (0.50-0.95)                         
                       Recessive      A/A-A/G    318 (80.5%)     251 (84.2%)     1                  0.200         949.5   958.5
                                      G/G        77 (19.5%)      47 (15.8%)      0.77 (0.52-1.15)                         
                       Overdominant   A/A-G/G    193 (48.9%)     159 (53.4%)     1                  0.240         949.7   958.8
                                      A/G        202 (51.1%)     139 (46.6%)     0.84 (0.62-1.13)                         
                       Log-additive   \-\--      \-\--           \-\--           0.78 (0.63-0.97)   **0.025\***   946.1   955.2
  rs11225394 (MMP-8)   Codominant     C/C        327 (84.7%)     234 (78.3%)     1                  **0.021\***   936.8   950.4
                                      T/C        57 (14.8%)      65 (21.7%)      1.59 (1.08-2.36)                         
                                      T/T        2 (0.5%)        0 (0%)          0.00 (0.00-NA)                           
                       Dominant       C/C        327 (84.7%)     234 (78.3%)     1                  **0.030\***   937.8   946.9
                                      T/C-T/T    59 (15.3%)      65 (21.7%)      1.54 (1.04-2.27)                         
                       Recessive      C/C-T/C    384 (99.5%)     299 (100%)      1                  0.130         940.2   949.3
                                      T/T        2 (0.5%)        0 (0%)          0.00 (0.00-NA)                           
                       Overdominant   C/C-T/T    329 (85.2%)     234 (78.3%)     1                  **0.018\***   937     946
                                      T/C        57 (14.8%)      65 (21.7%)      1.60 (1.08-2.38)                         
                       Log-additive   \-\--      \-\--           \-\--           1.46 (1.00-2.13)   0.052         938.8   947.8

SNP, single nucleotide polymorphism; ORs, odds ratios; CI, confidence interval; AIC, Akaike\'s Information criterion; BIC, Bayesian Information criterion.

*P* value was calculated with logistic analysis. \* *P* \< 0.05, statistical significance.

Furthermore, we found that the results were still superior after adjusting for age, and we also found another SNP (rs2012390) on *MMP-8* that was significant but not superior. After adjusting for age, we found, as shown in Table [4](#T4){ref-type="table"}, that rs650108 on *MMP-3* was associated with a decreased alcohol-induced ONFH risk in the dominant model (OR = 0.68, 95% CI = 0.49-0.95, *P* = 0.022) and the log-additive model (OR = 0.78, 95% CI = 0.63-0.98, *P* = 0.030), and rs11225394 on *MMP-8* was associated with an increased risk of alcohol-induced ONFH in the codominant model (OR = 1.72, 95% CI = 1.15-2.58, *P* = 0.010), the dominant model (OR = 1.67, 95% CI = 1.12-2.48, *P* = 0.012), the over-dominant model (OR = 1.73, 95% CI = 1.16-2.59, *P* = 0.007), and the log-additive model (OR = 1.57, 95% CI = 1.07-2.32, *P* = 0.022). Additionally, we found that rs2012390 on *MMP-8* was significant and associated with a decreased alcohol-induced ONFH risk in the dominant model (OR=0.72, 95% CI = 0.53-0.97, *P* = 0.032) and the log-additive model (OR = 0.77, 95% CI = 0.60-0.98, *P* = 0.035).

###### Analysis of the association between SNPs and alcohol-induced ONFH risk in males (adjusted for age)

  SNP ID               Model          Genotype   Group=control   Group=Alcohol   OR (95% CI)        *P*-value     AIC     BIC
  -------------------- -------------- ---------- --------------- --------------- ------------------ ------------- ------- -------
  rs650108 (MMP-3)     Codominant     A/A        116 (29.4%)     112 (37.6%)     1                  0.066         925.6   943.7
                                      A/G        202 (51.1%)     139 (46.6%)     0.70 (0.49-0.98)                         
                                      G/G        77 (19.5%)      47 (15.8%)      0.64 (0.41-1.01)                         
                       Dominant       A/A        116 (29.4%)     112 (37.6%)     1                  **0.022\***   923.7   937.3
                                      A/G-G/G    279 (70.6%)     186 (62.4%)     0.68 (0.49-0.95)                         
                       Recessive      A/A-A/G    318 (80.5%)     251 (84.2%)     1                  0.270         927.8   941.4
                                      G/G        77 (19.5%)      47 (15.8%)      0.80 (0.53-1.19)                         
                       Overdominant   A/A-G/G    193 (48.9%)     159 (53.4%)     1                  0.190         927.2   940.9
                                      A/G        202 (51.1%)     139 (46.6%)     0.81 (0.60-1.11)                         
                       Log-additive   \-\--      \-\--           \-\--           0.78 (0.63-0.98)   **0.030\***   924.3   937.9
  rs2012390 (MMP-8)    Codominant     A/A        189 (47.7%)     165 (55.4%)     1                  0.095         928.2   946.4
                                      A/G        174 (43.9%)     113 (37.9%)     0.73 (0.53-1.00)                         
                                      G/G        33 (8.3%)       20 (6.7%)       0.65 (0.36-1.19)                         
                       Dominant       A/A        189 (47.7%)     165 (55.4%)     1                  **0.032\***   926.4   940
                                      A/G-G/G    207 (52.3%)     133 (44.6%)     0.72 (0.53-0.97)                         
                       Recessive      A/A-A/G    363 (91.7%)     278 (93.3%)     1                  0.330         930     943.6
                                      G/G        33 (8.3%)       20 (6.7%)       0.75 (0.42-1.35)                         
                       Overdominant   A/A-G/G    222 (56.1%)     185 (62.1%)     1                  0.100         928.2   941.9
                                      A/G        174 (43.9%)     113 (37.9%)     0.77 (0.56-1.05)                         
                       Log-additive   \-\--      \-\--           \-\--           0.77 (0.60-0.98)   **0.035\***   926.5   940.1
  rs11225394 (MMP-8)   Codominant     C/C        327 (84.7%)     234 (78.3%)     1                  **0.001\***   914.9   933
                                      T/C        57 (14.8%)      65 (21.7%)      1.72 (1.15-2.58)                         
                                      T/T        2 (0.5%)        0 (0%)          0.00 (0.00-NA)                           
                       Dominant       C/C        327 (84.7%)     234 (78.3%)     1                  **0.012\***   915.8   929.4
                                      T/C-T/T    59 (15.3%)      65 (21.7%)      1.67 (1.12-2.48)                         
                       Recessive      C/C-T/C    384 (99.5%)     299 (100%)      1                  0.140         920     933.5
                                      T/T        2 (0.5%)        0 (0%)          0.00 (0.00-NA)                           
                       Overdominant   C/C-T/T    329 (85.2%)     234 (78.3%)     1                  **0.007\***   914.8   928.4
                                      T/C        57 (14.8%)      65 (21.7%)      1.73 (1.16-2.59)                         
                       Log-additive   \-\--      \-\--           \-\--           1.57 (1.07-2.32)   **0.022\***   916.9   930.5

ORs, odds ratios; CI, confidence interval; AIC, Akaike\'s Information criterion; BIC, Bayesian Information criterion.

*P* value was adjusted by age and gender; \* *P* \< 0.05, statistical significance.

Our study used polymorphism detection to analyze the pairwise linkage disequilibrium (LD) of *MMP-3* and *MMP-8*. The parameters r^2^ and D′ were used to analyze the LD pattern, and the results are shown in Figure [1](#F1){ref-type="fig"} and Table [5](#T5){ref-type="table"} . We observed one block in *MMP-3*, including eight SNPs: rs639752, rs650108, rs520540, rs646910, rs602128, rs679620, rs678815, and rs522616. We used χ^2^ and logistic tests to analyze the haplotype (Table [5](#T5){ref-type="table"}). The CGATATGT sequence was found to be associated with a significantly decreased alcohol-induced ONFH risk after adjustment for age (OR = 0.75, 95% CI = 0.57-0.97, *P* = 0.029). Additionally, we did not find any association between alcohol-induced ONFH and *MMP-8* after analyzing the pairwise LD, the results are shown in Table [6](#T6){ref-type="table"} and Figure [2](#F2){ref-type="fig"}.

![We used the parameters r2 and D′ to analyze the linkage disequilibrium (LD) of the SNPs on *MMP-3*\
Significant LD is indicated by bright red standard colors.](oncotarget-08-25177-g001){#F1}

###### Haplotype association with response (n=695, adjusted by age)

         rs639752   rs650108   rs520540   rs646910   rs602128   rs679620   rs678815   rs522616   Freq     OR (95% CI)          *P*-value
  ------ ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- -------------------- -------------
  1      A          A          G          T          G          C          C          C          0.3655   1                    \-\--
  2      C          G          A          T          A          T          G          T          0.3367   0.75 (0.57 - 0.97)   **0.029\***
  3      A          A          G          T          G          C          C          T          0.2079   0.88 (0.65 - 1.18)   0.380
  4      A          G          G          A          G          C          C          T          0.0849   0.75 (0.50 - 1.14)   0.190
  rare   \*         \*         \*         \*         \*         \*         \*         \*         0.005    0.47 (0.08 - 2.75)   0.400

Global haplotype association *P*-value: 0.19

rs639752, rs650108, rs520540, rs646910, rs602128, rs679620, rs678815 and rs522616 are on gene *MMP-3*

ORs, odds ratios; CI, confidence interval;

\* *P* \< 0.05, statistical significance.

###### Haplotype association with response (n=695, adjusted by age)

      rs3740938   rs2012390   rs1940475   rs11225394   rs11225395   Freq     OR (95% CI)          *P*-value
  --- ----------- ----------- ----------- ------------ ------------ -------- -------------------- -----------
  1   G           A           C           C            G            0.6226   1                    \-\--
  2   A           G           T           C            A            0.2457   0.81 (0.62 - 1.05)   0.12
  3   G           A           T           T            A            0.0928   1.37 (0.93 - 2.03)   0.11
  4   G           G           T           C            A            0.0267   0.55 (0.26 - 1.13)   0.11
  5   G           G           T           C            G            0.0108   1.02 (0.35 - 2.97)   0.97

Global haplotype association *p*-value: 0.021

###### All the information of the primers in this case-control study

  Gene    SNP \_ID     1st-PCR primer sequences          2nd-PCR primer sequences         UEP sequences
  ------- ------------ --------------------------------- -------------------------------- ----------------------------
  MMP-3   rs639752     ACGTTGGATGCAGATAAATTCTCCACTTGC    ACGTTGGATGGGCTGCAATGCAGGGAAAAG   tGGGAAGAAAGAAATAGGTGAT
  MMP-3   rs650108     ACGTTGGATGGTCACTGTCTCATTGTGTGT    ACGTTGGATGTCAGGTAGAGGTGACAAGTG   tAAGTGGGTGAGGTTAGA
  MMP-3   rs520540     ACGTTGGATGGCGAAAGGGCTTAACTGTTAT   ACGTTGGATGCCAGCTCGTACCTCATTTCC   CTCGTACCTCATTTCCTCTGAT
  MMP-3   rs646910     ACGTTGGATGCCACTGTAAGCTGGTGACTA    ACGTTGGATGGTTAAGCCCTTTCGCTTTAG   CGCTTTAGAAATACACTTTAGCATCT
  MMP-3   rs602128     ACGTTGGATGCTTCGGGATGCCAGGAAA      ACGTTGGATGAAGCTGGACTCCGACACTCT   CAGGTGTGGAGTTCCTGA
  MMP-3   rs679620     ACGTTGGATGAACAGGACCACTGTCCTTTC    ACGTTGGATGAGAAATATCTAGAAAACTAC   tcTCTAGAAAACTACTACGACCTC
  MMP-3   rs678815     ACGTTGGATGAATGCAACGTAATTTTAGC     ACGTTGGATGTGGAGTATTTCTCTAGCTTG   TCTCTAGCTTGCTGAAATAATG
  MMP-3   rs522616     ACGTTGGATGCGTAGCTGCTCCATAAATAG    ACGTTGGATGACAGAGAGAATTTCAGTCCG   gaCGGTAAGCAATGTAATTCATTTCA
  MMP-8   rs3740938    ACGTTGGATGGTCAGTAAGAGGAATCAAAG    ACGTTGGATGTGACATTTGATGCTATCAC    GATGCTATCACCACACT
  MMP-8   rs2012390    ACGTTGGATGACTGTTTCTAGGTCACACCC    ACGTTGGATGTCAGGGAGAGGAAGCAATTC   gAAGCAAATGTGAGGAAGAT
  MMP-8   rs1940475    ACGTTGGATGTTTGGGTTGAATGTGACGGG    ACGTTGGATGTAAAACCACCACTGTCAGGC   CTCCACAGCGAGGCTTTT
  MMP-8   rs11225394   ACGTTGGATGCAATCTCAAACTAATCACCC    ACGTTGGATGTTAGGAAATAGTGTGGGTTG   AGTGTGGGTTGTTTTCTCTT
  MMP-8   rs11225395   ACGTTGGATGAGAGCTGCTGCTCCACTATG    ACGTTGGATGGTTTAGAGAGACTGAGCTGG   gCTGAGCTGGGAGCTACTATA

###### All the statistical power of the SNPs in this study

  SNP_ID       Gene(s)   case \_n1   control \_n2   case \_A   control \_A   case \_p1   contol \_p2   p          zβ         power
  ------------ --------- ----------- -------------- ---------- ------------- ----------- ------------- ---------- ---------- -----------------
  rs639752     MMP3      598         792            186        186           0.311037    0.234848      0.267626   1.206173   **0.886124538**
  rs650108     MMP3      596         790            233        233           0.39094     0.294937      0.336219   1.777753   **0.962277821**
  rs520540     MMP3      598         792            186        186           0.311037    0.234848      0.267626   1.206173   **0.886124538**
  rs646910     MMP3      598         792            46         46            0.076923    0.058081      0.066187   -0.55131   0.290709864
  rs602128     MMP3      596         782            187        187           0.313758    0.23913       0.271408   1.117555   **0.868121497**
  rs679620     MMP3      598         792            187        187           0.312709    0.236111      0.269065   1.217832   **0.88835615**
  rs678815     MMP3      592         790            185        185           0.3125      0.234177      0.267728   1.282388   **0.900146697**
  rs522616     MMP3      598         790            236        236           0.394649    0.298734      0.340058   1.768172   **0.961483907**
  rs3740938    MMP8      598         790            135        135           0.225753    0.170886      0.194524   0.590001   0.722404948
  rs2012390    MMP8      596         792            153        153           0.256711    0.193182      0.220461   0.85629    **0.804081313**
  rs1940475    MMP8      598         792            217        217           0.362876    0.27399       0.31223    1.571273   **0.941940363**
  rs11225394   MMP8      598         772            65         65            0.108696    0.084197      0.094891   -0.41971   0.337347429
  rs11225395   MMP8      598         792            210        210           0.351171    0.265152      0.302158   1.488018   **0.931626918**

![We used the parameters r2 and D′' to analyze the linkage disequilibrium (LD) of the SNPs on *MMP-8*\
Significant LD is indicated by bright red standard colors.](oncotarget-08-25177-g002){#F2}

DISCUSSION {#s3}
==========

Excessive and chronic alcohol consumption are the most important causes of alcohol-induced ONFH. The association between several polymorphisms and alcohol-induced ONFH has been reported \[[@R4], [@R11], [@R13], [@R18]\]\]. However, each polymorphism only contributes to a small relative risk of alcohol-induced ONFH, and more comprehensive genetic polymorphisms are needed to enrich the genetic information on this disease. Our study is the first to investigate the association between the *MMP-3* and *MMP-8* polymorphisms and alcohol-induced ONFH. We researched 13 SNPs on *MMP-3* and *MMP-8*, and found two protective SNPs, rs650108 (10556C\>T) on *MMP-3* and rs2012390 (9909C\>T), on *MMP-8* and one high-risk SNP, rs11225394 (5273G\>A), on *MMP-8* associated with alcohol-induced ONFH risk.

The destruction and repair of bone tissue depend on bone resorption and bone formation. They are the basis of bone metabolism. MMPs are a group of endopeptidases that contain zinc finger motifs, which have the function of degrading all the components of extracellular matrix. A study by Grässel et al \[[@R19]\] reported that the expression and activity of *MMP-2* and *MMP-9* increase the impaired bone matrix repair capacity, restoring the balance between bone resorption and de novo bone formation in ONFH. So *MMP-3* and *MMP-8*, might be like *MMP-2* and *MMP-9* and are associated with ONFH.

*MMP-3* and *MMP-8* localize to chromosome 11q22.3. *MMP-3* encodes an enzyme that degrades fibronectin, laminin, collagens III, IV, IX, and X, and cartilage proteoglycans. The expression of *MMP-3* involves in the degradation of bone matrix in bone resorption \[[@R14]\]. A previous study demonstrated that 6A/6A polymorphism of *MMP-3* is associated with the degradation of collagen, resulting in extracellular matrix degradation, ultimately leading to cartilage and bone loss \[[@R20]\], and this pathway is one of the major pathological mechanismsmechanism in ONFH. Our research found that rs650108 (10556C\>T) of *MMP-3* decreases the risk of alcohol-induced ONFH. We speculated that the polymorphism of *MMP-3* might be involvedinvolve in the prevention pathway of extracellular matrix degradation and decreasing cartilage and bone loss in ONFH. *MMP-8* encodes interstitial collagenases that promote bone tissue degradation. The expression of *MMP-8* involves in the breakdown of extracellular matrix in bony tissue development, reproduction, and tissue remodeling, including disease processes such as arthritis and metastasis \[[@R15]\]. Our research found that rs2012390 (9909C\>T) on *MMP-8* decreases ONFH risk and rs11225394 (5273G\>A) on *MMP-8* increases ONFH risk. The polymorphisms of *MMP-8* might influence the breakdown pathway of the extracellular matrix in bony tissue development, reproduction, and tissue remodeling, and is a risk or preventionprevent factor in ONFH. Previous studies have determined that *MMP-3* and *MMP-8* are key factors in the pathological process of orthopedic diseases \[[@R16], [@R21], [@R22]\]. For example, *MMP-1* and *MMP-3* encode the key enzyme for bone surface collagen formation. The expression of *MMP-1* and *MMP-3* promote bone resorption to accelerate sclerotin repair \[[@R23]\]. In osteoarthritis patients, *MMP-3* promotes the degradation of bone matrix and stimulates bone tissue repair \[[@R16]\]. We speculated that the SNPs rs650108 (10556C\>T) on *MMP-3* and rs2012390 (9909C\>T) on *MMP-8* might decrease alcohol-induced ONFH risk by regulating the breakdown of the extracellular matrix (ECM) and finally result in regulating bone tissue repair.; We also found rs11225394 (5273G\>A) on *MMP-8*increases alcohol-induced ONFH risk. Thethe role of *MMP-3* is supposedly related to the breakdown of the ECM, resulting in the loss of tissue integrity \[[@R24]\].Additionally, *MMP-3* is a factor in the formation of bone tissue and in the formation of osteoclasts, osteoblasts, osteoid and pro-osteoclasts \[[@R25]\]. Osteoclasts are differentiated from pro-osteoclasts, and the dynamic equilibrium of the osteoblast/osteoclast ratio is the major part of the maintenance of bone resorption, bony remodeling, and bone metabolism. We found that the genetic polymorphisms of *MMP-3*, rs650108 (10556C\>T), decrease ONFH risk.We speculated that thethe polymorphism of *MMP-3* might on the one hand regulate the breakdown of the ECM and on the other hand influence the formation of osteoblasts and osteoclasts and influence bone metabolism, resulting in decreased alcohol-induced ONFH risk. *MMP-8* is mainly produced by neutrophils and is also expressed by extensive cells, including chondrocytes \[[@R26]\] and synovial fibroblasts \[[@R27]\]. *MMP-8* is a key factor in the pathogenesis of several inflammatory conditions because is encodes a potent collagenolytic enzyme \[[@R28]\]. The action of *MMP-8* in the inflammatory process depends on the stimulus in different situations, and *MMP-8* might have a promoting or protective function in arthritis pathogenesis \[[@R29], [@R30]\]. A previous investigation indicated that the polymorphism of *MMP-8* influencesinfluence the development of the inflammatory reaction itself \[[@R31]\]. A lack of *MMP-8* causes the aggravation of arthritis through promotion of inflammation by IL-1β and PTX3, inducing the maturation and activation of osteoclasts or enhancement of the inflammatory infiltrate by PROKR2 and IL-1β \[[@R32]\]. So, we speculated that the polymorphisms of *MMP-8* mightmight influence the development of the inflammatory reaction process in the femoral head, and might be involvedand involve in the regulation of the inflammatory response in the bone joint tissue, resulting in an influence on the risk of alcohol-induced ONFH. Additionally, rs650108 (10556C\>T) is a sensitive SNP in *MMP-3* that has been found to have an association with the risk of primary sclerosing cholangitis \[[@R33]\], breast cancer \[[@R34]\], and rotator cuff repair \[[@R35]\]. The mutation of rs650108 in these diseases are a key factor in inflammatory or fibrogenic response, and the pathogenic development of alcohol-induced ONFH is closely tied to the fibrogenic response of bone resorption and remodeling of bone tissue. Thus, we speculated that the mutation of rs650108 on *MMP-3* may influence the process of bone resorption and remodeling that is associated with the fibrogenic response in alcohol-induced ONFH. MoreoverMoreover, we found the expression of a different genotype in a different SNP on the same gene might have a different influence in the same disease.

Furthermore, our study is the first to explore the association between alcohol-induced ONFH and *MMP-3* and *MMP-8* polymorphism. Further explorations with larger samples and individuals from different areas are needed to confirm our conclusion.

MATERIALS AND METHODS {#s4}
=====================

Ethics committee statement {#s4_1}
--------------------------

Our present study strictly observed the principles of the Declaration on Helsinki of the World Medical Association and was approved by the Ethics Committee of Zhengzhou Traditional Chinese Medicine Traumatology Hospital. Informed consent forms were signed by all the individuals and they were all notified for our case-control study.

Research subjects {#s4_2}
-----------------

Our case-control study consecutively recruited a total of 695 male individuals (299 alcohol-induced ONFH patients and 396 healthy control subjects) from September 2014 to January 2016 in Zhengzhou Traditional Chinese Medicine Traumatology Hospital. All the participants were selected randomly without age restriction and were genetically unrelated ethnic Han Chinese males.

Medical diagnostic criteria of alcohol-induced ONFH is based on clinical manifestations such as pain and activity limitation of hip and sick-side lower limb muscle atrophy. Further diagnosis depends on magnetic resonance imaging (MRI) analysis and examination of changes on X-ray, such as high density shadows of the femoral head, hip joint narrowness and bumpiness, or joint surface rupture. All the selected patients were given thorough physical examinations.

When we selected the participants for the case group, the exclusion criteria were refusal to participate in this study, liver disease or dyslipidemia caused by drugs, not satisfying alcohol-induced ONFH medical diagnostic criteria or the presence of traumatic osteonecrosis or other hip diseases, requirement of steroids for replacement therapy in serious primary disease, and overuse of steroids or a chronic metabolic disorder of the heart, kidney, or liver.

When we selected the control group, all the individuals were healthy. We collected the epidemiological information by using a standardized questionnaire and collected clinical information from medical records and pathological reports.

SNP sites selection {#s4_3}
-------------------

A total of 13 single nucleotide polymorphisms (SNPs), including eight SNPs on the gene *MMP-3* and five on the gene *MMP-8*, were selected for our study. Most of the 13 SNPs had not been reported in the past. However, several SNPs were related to some other disease, such as frozen shoulder \[[@R36]\], breast cancer \[[@R34]\], carpal tunnel syndrome \[[@R37]\], rheumatoid arthritis (RA) \[[@R38]\], or osteoarthritis (OA) \[[@R39]\]. The selection of SNPs depended on their location, allele frequencies, and disease relevance determined by use of the Hapmap public databases (dbSNP; [http://www.ncbi.nlm.nih.gov/SNP/](http://www.ncbi.nlm.nih.gov/SNP/,), HAPMAP; <http://www.Hapmap.org/index.html.en>). The minor allele frequency (MAF) is higher than 5% in the HapMap Chinese Han Beijing (CHB) population.

Genotyping {#s4_4}
----------

We extracted genomic DNA from whole blood samples by using a purification kit (GoldMag, China), and then stored the extract at a temperature of −20° C. We measured the DNA concentration by spectrometry (DU530 UV/VIS spectrophotometer, Beckman Instruments, Fullerton, CA, USA). Per the manufacturer\'s instructions, we performed the genotyping by using the Sequenom MassARRAY® RS1000 system. The amplification and extension of primers were completed by application of Sequenom MassARRAY® Assay Design 3.0 software \[[@R40]\]. We also utilized Sequenom Typer 4.0 software to analyze and manage our data \[[@R40], [@R41]\].

Statistical analysis {#s4_5}
--------------------

We utilized SPSS17.0 statistical software (SPSS, Chicago, IL) and Microsoft Excel to calculate the statistical analyses of our study. *P* ≤ 0.05 indicates statistical significance and all the *P*-values are two-sided. The SNP genotype frequencies in our case and control groups were performed by χ^2^ tests. We used the Hardy-Weinberg equilibrium (HWE) to check the genotype frequency of the individuals in the control group. To make sure the results of our study are credible and to assess the relation between SNPs and alcohol-induced ONFH risk, unconditional logistic regression analysis with adjustment for age was used to examined constructed 95% confidence intervals (95% CIs) and odds ratios (ORs) \[[@R42]\], and the adjustment for age was done for the dominant, recessive, codominant and log-additive models. In addition, we used Haploview 4.2 to test the linkage disequilibrium structure.

Limitations {#s4_6}
-----------

Our study had some limitations. First, patients were only enrolled in one hospital, which may increase the false-positive rate by avoiding the selection bias. This bias was not meaningful because the genetic frequencies and the difference in the distribution of demographic segmentation had been dissolved into nothingness. Second, because the number of alcohol-induced ONFH patients was not large, the sample size of our case-control study was not large. If we increase the sample size, some negative results might change to positive results that could make our conclusion more powerful and meaningful. The population was not stratified by the amount of alcohol consumption, and we did not confirm that this locus was significant for drinkers. Third, we did not evaluate the heterogeneity of alcohol consumption and the comorbidities, but in a previous study, evaluation of heterogeneity in drinking behaviors contributed to progress in elucidating the pathogenesis of alcohol-induced ONFH \[[@R43]\].

CONCLUSION {#s5}
==========

We investigated 13 SNPs to explore the relation of polymorphisms of the genes *MMP-3* and *MMP-8* to alcohol-induced ONFH risk in Chinese males. We found that genetic polymorphisms of rs650108 (10556C\>T) in *MMP-3* and rs2012390 (9909C\>T) in *MMP-8* decreased alcohol-induced ONFH, and rs11225394 (5273G\>A) on *MMP-8* with polymorphism significantly increased the risk of alcohol-induced ONFH. The mutation of the three SNPs might promote the degradation of bone matrix and influence the breakdown of extracellular matrix, the formation of osteoclasts and osteoblasts, or the activation of the inflammatory response to regulate the osteoblast/osteoclast ratio, bony tissue development, reproduction, and tissue remodeling, and then lead to the repair of bone tissue in the femoral head, and that associated with alcohol-induced ONFH risk.
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